Discussion

Dr Shaf Keshavjee (Toronto, Ontario, Canada). Congratulations, Konrad, on an outstanding presentation, and I would like to also congratulate the Vienna group on their outstanding leadership in this area of extracorporeal membrane oxygenation (ECMO) support and ECMO in lung transplantation. I have no specific conflicts of interest to declare. Konrad, the first question I have for you is the primary graft dysfunction rate was not significantly different between the ECMO and the no ECMO group, but the long-term survival, as you have shown, was impressively better.

from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader https://ift.tt/2GQCcch